Replies to post #123908 on PharmaCyte Biotech Inc (PMCB)

[DragonBear]

Changes NOTHING...Correct!!!

irrelevancy changes ABSOLUTELY NOTHING!!!

Continuous references to Hidalgo, recycling "IFs" "could" changes ABSOLUTELY NOTHING!!!

The IND has not been submitted.

Any IND for a Phase 2b will be rejected by the FDA. Any Hidalgo involvement in designing the test protocol is an irrelevancy.

“A N T I Q U A T E D” technology!

Agreed!!!